Immunohistochemical demonstration of the amphetamine derivatives 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in human post-mortem brain tissues and the pituitary gland

International Journal of Legal Medicine

Volumn 117, Issue 1, 2003, Pages 2-9

  De Letter, Els A ^a   Espeel, Marc F A ^a   Craeymeersch, Marijke E C ^a   Lambert, Willy E ^a   Clauwaert, Karine M ^a   Dams, Riet ^a   Mortier, Kjell A ^a   Piette, Michel H A ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

3,4 Methylenedioxyamphetamine (MDA); 3,4 Methylenedioxymethamphetamine (MDMA); Human brain; Immunohistochemistry; Pituitary gland

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE;

ARTICLE; AUTOPSY; BASAL GANGLION; BRAIN STEM; CEREBELLUM VERMIS; CONTROLLED STUDY; CORPUS CALLOSUM; DRUG ABUSE; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; FORENSIC MEDICINE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HYPOPHYSIS; IMMUNOHISTOCHEMISTRY; MALE; MEDULLA OBLONGATA; PERIKARYON; PONS; PRIORITY JOURNAL; WHITE MATTER;

EID: 0038120947     PISSN: 09379827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00414-002-0290-2     Document Type: Article

References (32)

1. De Letter EA, Coopman VAE, Cordonnier JACM, Piette MHA (2001) One fatal and seven non-fatal cases of 4-methylthioamphetamine (4-MTA) intoxication: clinico-pathological findings. Int J Legal Med 114:352-356
2. Dowling GP, McDonough ET III, Bost RO (1987) 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA. JAMA 257:1615-1617
3. Rohrig TP, Prouty RW (1992) Tissue distribution of methylenedioxymethamphetamine. J Anal Toxicol 16:52-53
4. Fineschi V, Masti A (1996) Fatal poisoning by MDMA (ecstasy) and MDEA: a case report. Int J Legal Med 108:272-275
5. De Letter EA, Clauwaert KM, Lambert WE, Van Bocxlaer JF, De Leenheer AP, Piette MHA (2002) Distribution study of 3,4-methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine (MDA) in a fatal overdose. J Anal Toxicol 26:113-118
6. Decaestecker T, De Letter E, Clauwaert K, Bouche MP, Lambert W, Van Bocxlaer J, Piette M, Van den Eeckhout E, Van Peteghem C, De Leenheer A (2001) Fatal 4-MTA intoxication: development of a liquid chromatographic-tandem mass spectrometric assay for multiple matrices. J Anal Toxicol 25:705-710
7. Moriya F, Hashimoto Y (1999) Redistribution of basic drugs into cardiac blood from surrounding tissues during early-stages postmortem. J Forensic Sci 44:10-16
8. Hilberg T, Ripel Å, Slørdal L, Bjomeboe A, Mørland J (1999) The extent of postmortem drug redistribution in a rat model. J Forensic Sci 44:956-962
9. De Letter EA, De Paepe P, Clauwaert KM, Belpaire FM, Lambert WE, Van Bocxlaer JF, Piette MHA (2000) Is vitreous humour useful for the interpretation of 3,4-methylenedioxymeth-amphetamine (MDMA) blood levels? Experimental approach with rabbits. Int J Legal Med 114:29-35
10. Balkon J, Bidanset JH, Lynch VD (1980) Immunofluorescence detection of drugs in postmortem tissues: a new technique with potential for assessment of drug influence in cause of death. J Forensic Sci 25:88-94
11. Morley M, Gee DJ (1982) An assessment of the immunofluorescence technique as a method for demonstrating the histological localization of tetrahydrocannabinol in mammalian tissues. J Forensic Sci 27:837-843
12. Ishiyama I, Mukaida M, Tanabe R, Kaiho M, Ueyama M (1987) Histochemical demonstration of phenobarbital by immunocytochemistry. J Forensic Sci 32:1221-1234
13. Wehner F, Wehner H-D, Subke J, Meyermann R, Fritz P (2000) Demonstration of morphine in ganglion cells of the hippocampus from victims of heroin overdose by means of antimorphine antiserum. Int J Legal Med 113:117-120
14. Wehner F, Wehner H-D, Schieffer MC, Subke J (2000) Immunohistochemical detection of methadone in the human brain. Forensic Sci Int 112:11-16
15. Hood I, Mirchandani H, Monforte J, Stacer W (1986) Immunohistochemical demonstration of homicidal insulin injection site. Arch Pathol Lab Med 110:973-974
16. Lutz R, Pedal I, Wetzel C, Mattem R (1997) Insulin injection sites: morphology and immunohistochemistry. Forensic Sci Int 90:93-101
17. Wehner F, Mittmeyer H-J, Wehner H-D, Schieffer MC (1998) Insulin- or morphine-injection? Immunohistochemical contribution to the elucidation of a case. Forensic Sci Int 95:241-246
18. Battaglia G, Zaczek R, Souza EB de (1990) MDMA effects in brain: pharmacologic profile and evidence of neurotoxicity from neurochemical and autoradiographic studies. In: Peroutka SJ (ed) Ecstasy: the clinical, pharmacological and neurotoxicological effects of the drug MDMA. Kluwer Academic Publishers, Boston, Dordrecht, London, pp 171-199
19. Feldman RS, Meyer JS, Quenzer LF (eds) (1997) Principles of neuropsychopharmacology, Chapter 9. Serotonin. Sinauer Associates, Inc Sunderland, Massachusetts, pp 358-359
20. Battaglia G, Sharkey J, Kuhar MJ, Souza EB de (1991) Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography. Synapse 8:249-260
21. McCann UD, Mertl M, Eligulashvili V, Ricaurte GA (1999) Cognitive performance in (±)3,4 -methylenedioxymethamphetamine (MDMA, "Ecstasy") users: a controlled study. Psychopharmacology 143:417-425
22. Fischer C, Hatzidimitriou G, Wlos J, Katz J, Ricaurte G (1995) Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (±)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"). J Neurosci 15:5476-5485
23. Fineschi V, Centini F, Mazzeo E, Turillazzi E (1999) Adam (MDMA) and Eve (MDEA) misuse: an immunohistochemical study on three fatal cases. Forensic Sci Int 104:65-74
24. Ishiyama I, Mukaida M, Yoshii T, Suyama H (1987) Histochemical demonstration of methamphetamine by immunocytochemistry. J Forensic Sci 32:658-672
25. Clauwaert KM, Van Bocxlaer JF, De Letter EA, Van Calenbergh S, Lambert WE, De Leenheer AP (2000) Determination of the designer drugs 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxyethylamphetamine, and 3,4-methylenedioxy-amphetamine with HPLC and fluorescence detection in whole blood, serum, vitreous humor, and urine. Clin Chem 46:1968-1977
26. Clauwaert KM, Van Bocxlaer JF, Lambert WE, De Leenheer AP (1996) Analysis of cocaine, benzoylecgonine, and cocaethylene in urine by HPLC with diode array detection. Anal Chem 68:3021-3028
27. Clauwaert KM, Van Bocxlaer JF, Lambert WE, De Leenheer AP (1997) Liquid chromatographic determination of cocaine, benzoylecgonine, and cocaethylene in whole blood and serum samples with diode-array detection. J Chromatogr Sci 35:321-328
28. Espeel M, Van Limbergen G (1995) Immunocytochemical localization of peroxisomal proteins in human liver and kidney. J Inherit Metab Dis 18 (S1):135-154
29. Kalasinsky KS, Bosy TZ, Schmunk GA, Reiber G, Anthony RM, Furukawa Y, Guttman M, Kish SJ (2001) Regional distribution of methamphetamine in autopsied brain of chronic human methamphetamine users. Forensic Sci Int 116:163-169
30. Hatzidimitriou G, McCann UD, Ricaurte GA (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with (±)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19:5096-5107
31. Bolla KI, McCann UD, Ricaurte GA (1998) Memory impairment in abstinent MDMA ("Ecstasy") users. Neurology 51:1532-1537
32. Mas M, Farré M, Torre R de la, Roset PN, Ortuño J, Segura J, Camí J (1999) Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxy-methamphetamine in humans. J Pharmacol Exp Ther 290:136-145